NT5E and lung carcinoma: CD73, known as ecto-5′-nucleotidase, is a novel immune checkpoint associated with adenosine metabolism that indirectly promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis [184] In several tumors, including lung cancer, CD73 is upregulated, and its higher expression is associated with poor outcomes [184,185,186,187].